Angiotensin II receptor blocker or angiotensin-converting enzyme inhibitor use and COVID-19-related outcomes among US Veterans

BACKGROUND: Angiotensin II receptor blockers (ARBs) and angiotensin-converting enzyme inhibitors (ACEIs) may positively or negatively impact outcomes in severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. We investigated the association of ARB or ACEI use with coronavirus disease...

Descripción completa

Detalles Bibliográficos
Autores principales: Derington, Catherine G., Cohen, Jordana B., Mohanty, April F., Greene, Tom H., Cook, James, Ying, Jian, Wei, Guo, Herrick, Jennifer S., Stevens, Vanessa W., Jones, Barbara E., Wang, Libo, Zheutlin, Alexander R., South, Andrew M., Hanff, Thomas C., Smith, Steven M., Cooper-DeHoff, Rhonda M., King, Jordan B., Alexander, G. Caleb, Berlowitz, Dan R., Ahmad, Faraz S., Penrod, M. Jason, Hess, Rachel, Conroy, Molly B., Fang, James C., Rubin, Michael A., Beddhu, Srinivasan, Cheung, Alfred K., Xian, Weiming, Weintraub, William S., Bress, Adam P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8064574/
https://www.ncbi.nlm.nih.gov/pubmed/33891615
http://dx.doi.org/10.1371/journal.pone.0248080

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8064574/
https://www.ncbi.nlm.nih.gov/pubmed/33891615
http://dx.doi.org/10.1371/journal.pone.0248080

Ejemplares similares